Literature DB >> 3453455

Total hip replacement in the neuromuscularly impaired.

H D Skoff1, K Keggi.   

Abstract

UNLABELLED: Controversy exists over the appropriate use of total hip arthroplasty in patients with significant neuromuscular disease. This study investigated the use of THR in neuromuscular disease patients. A criterion for patient inclusion was a diagnosis of mental retardation, cerebral palsy or Down's syndrome. The study population consisted of nine patients (12 hips), average age, 42 years. Average follow-up was 3.5 years.
RESULTS: (1) 100% of patients demonstrated decreased pain, expanded range of motion and improved overall function. (2) All institutionalized patients were cared for more easily. (3) There were no infections, dislocations or major complications.
CONCLUSION: Total hip arthroplasty is a reasonable and safe therapeutic option for the treatment of painful osteoarthritis of the hip in select patients with neuromuscular disease.

Entities:  

Mesh:

Year:  1986        PMID: 3453455

Source DB:  PubMed          Journal:  Orthop Rev        ISSN: 0094-6591


  6 in total

1.  [Total hip arthroplasty by neuromuscular impairment: functional outcome].

Authors:  S Endres; Z Lovric; A Wilke; T Meiners
Journal:  Orthopade       Date:  2012-11       Impact factor: 1.087

2.  [Total hip arthroplasty in cerebral palsy].

Authors:  C M Schörle; G Fuchs; G Manolikakis
Journal:  Orthopade       Date:  2006-08       Impact factor: 1.087

Review 3.  Feasibility of total hip arthroplasty in cerebral palsy patients: a systematic review on clinical outcomes and complications.

Authors:  Catalina Larrague; Cecilia Fieiras; Diego Campelo; Fernando M Comba; Gerardo Zanotti; Pablo A Slullitel; Martin A Buttaro
Journal:  Int Orthop       Date:  2022-08-02       Impact factor: 3.479

Review 4.  Hip surveillance and management of the displaced hip in cerebral palsy.

Authors:  J E Robb; G Hägglund
Journal:  J Child Orthop       Date:  2013-08-18       Impact factor: 1.548

5.  Difficulty in securing treatment for degenerative hip disease in a patient with Down syndrome: the gap remains open.

Authors:  Chandler E Gill; Henry M Taylor; K T Lin; Bimal B Padaliya; William J Newman; Anna I Abramovitch; CaraLee R Richardson; P David Charles
Journal:  J Natl Med Assoc       Date:  2006-01       Impact factor: 1.798

6.  Long-term results of hip arthroplasty in ambulatory patients with cerebral palsy.

Authors:  Kerstin Schroeder; Christian Hauck; Bernd Wiedenhöfer; Frank Braatz; Peter R Aldinger
Journal:  Int Orthop       Date:  2009-04-22       Impact factor: 3.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.